Literature DB >> 31605176

Ineffective Esophageal Motility in Patients with GERD is no Contraindication for Nissen Fundoplication.

Milena Nikolic1, Katrin Schwameis1, Ivan Kristo1, Matthias Paireder1, Aleksa Matic1, Georg Semmler1, Lorenz Semmler1, Sebastian F Schoppmann2.   

Abstract

BACKGROUND: Patients with preoperative ineffective esophageal motility (IEM) are thought to be at increased risk for postoperative dysphagia leading to the recommendations for tailoring or avoiding anti-reflux surgery in these patients. The aim of this study was to evaluate if IEM has an influence on postoperative outcome after laparoscopic Nissen fundoplication (LNF).
METHODS: Seventy-two consecutive patients with IEM underwent LNF and were case-matched with 72 patients without IEM based on sex, age, BMI, HH size, total pH percentage time, total number of reflux episodes and the presence of BE. Standardized interview assessing postoperative gastrointestinal symptoms, proton pump inhibitor intake, GERD-health-related-quality-of-life (GERD-HRQL), alimentary satisfaction and patients' overall satisfaction was evaluated.
RESULTS: Although a higher rate of preoperative dysphagia was observed in patients with IEM (29% IEM vs. 11% no IEM, p = 0.007), there was no significant difference in rates of dysphagia postoperatively (2 IEM vs. 1 no IEM, p = 0.559). Furthermore, no distinction was found in the postoperative outcome regarding symptom relief, quality of life, gas bloating syndrome, ability to belch and/or vomit or revision surgery between the two groups.
CONCLUSION: Although preoperative IEM has an influence on GERD presentation, it has no effect on postoperative outcome after LNF. IEM should not be a cause for avoiding LNF, as is has been shown as the most effective and safe anti-reflux treatment.

Entities:  

Year:  2020        PMID: 31605176     DOI: 10.1007/s00268-019-05229-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Evaluation of laparoscopic Toupet fundoplication as a primary repair for all patients with medically resistant gastroesophageal reflux.

Authors:  B A Jobe; J Wallace; P D Hansen; L L Swanstrom
Journal:  Surg Endosc       Date:  1997-11       Impact factor: 4.584

2.  Patient outcomes and dysphagia after laparoscopic antireflux surgery performed without use of intraoperative esophageal dilators.

Authors:  Jason D Walsh; Jeffrey Landercasper; William C Boyd; Pamela J Lambert; Paul J Havlik
Journal:  Am Surg       Date:  2003-03       Impact factor: 0.688

3.  Effect of an esophageal bougie on the incidence of dysphagia following nissen fundoplication: a prospective, blinded, randomized clinical trial.

Authors:  E J Patterson; D M Herron; P D Hansen; N Ramzi; B A Standage; L L Swanström
Journal:  Arch Surg       Date:  2000-09

4.  The Chicago Classification of esophageal motility disorders, v3.0.

Authors:  P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2014-12-03       Impact factor: 3.598

Review 5.  The history of hiatal hernia surgery: from Bowditch to laparoscopy.

Authors:  Nicholas Stylopoulos; David W Rattner
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

6.  Can different subsets of ineffective esophageal motility influence the outcome of nissen fundoplication?

Authors:  Aleksandar P Simić; Ognjan M Skrobić; Richard R Gurski; Vladimir M Šljukić; Nenad R Ivanović; Predrag M Peško
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

7.  Omission of the calibration bougie in laparoscopic repair of paraesophageal hernia.

Authors:  Ada Ng; David Yong; Eric Hazebroek; Hayley Berry; Richard Radajewski; Steven Leibman; Garett S Smith
Journal:  Surg Endosc       Date:  2009-04-03       Impact factor: 4.584

8.  Laparoscopic floppy Nissen fundoplication: 11-year follow-up.

Authors:  Mario Schietroma; Fabiola De Vita; Francesco Carlei; Sergio Leardi; Beatrice Pessia; Federico Sista; Gianfranco Amicucci
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2013-06       Impact factor: 1.719

9.  Long-term follow-up after laparoscopic refundoplication for failed antireflux surgery: quality of life, symptomatic outcome, and patient satisfaction.

Authors:  Frank A Granderath; Thomas Kamolz; Ursula M Schweiger; Rudolph Pointner
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

10.  Dynamics of quality of life improvement after floppy Nissen fundoplication for gastroesophageal reflux disease.

Authors:  Jarek Kobiela; Łukasz Kaska; Magdalena Pindel; Arkadiusz Szarmach; Maria Janiak; Monika Proczko-Markuszewska; Tomasz Stefaniak; Dariusz Łaski; Andrzej Łachiński; Zbigniew Śledziński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-16       Impact factor: 1.195

View more
  4 in total

1.  Patients with ineffective esophageal motility benefit from laparoscopic antireflux surgery.

Authors:  Alex Addo; Philip George; H Reza Zahiri; Adrian Park
Journal:  Surg Endosc       Date:  2020-09-21       Impact factor: 4.584

Review 2.  Current Advancement on the Dynamic Mechanism of Gastroesophageal Reflux Disease.

Authors:  Zhi Zheng; Yuxi Shang; Ning Wang; Xiaoye Liu; Chenglin Xin; Xiaosheng Yan; Yuhao Zhai; Jie Yin; Jun Zhang; Zhongtao Zhang
Journal:  Int J Biol Sci       Date:  2021-10-03       Impact factor: 6.580

3.  Laparoscopic Fundoplication Is Effective Treatment for Patients with Gastroesophageal Reflux and Absent Esophageal Contractility.

Authors:  Steven Tran; Ronan Gray; Feruza Kholmurodova; Sarah K Thompson; Jennifer C Myers; Tim Bright; Tanya Irvine; David I Watson
Journal:  J Gastrointest Surg       Date:  2021-04-26       Impact factor: 3.452

4.  Additional fundophrenicopexia, after Nissen fundoplication, reduces postoperative dysphagia and re-operation rate in the long-term follow up.

Authors:  Milena Nikolic; Aleksa Matic; Ivan Kristo; Matthias Paireder; Reza Asari; Bogdan Osmokrovic; Georg Semmler; Sebastian F Schoppmann
Journal:  Surg Endosc       Date:  2021-06-22       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.